Clinical Trials Browser

Active not recruiting × OTHER × HMPL-013 × Clear all

NCT07491159 2026-03-24

Fruquintinib Plus Checkpoint Inhibitor Combined or Sequential TAS-102 in Colorectal Cancer Patients Who Progressed on Second-line Standard Therapy: a Prospective, Multi-cohort, Single-centered, Phase Ib/II Study

Phase 1/2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06356597 2026-02-24

Tislelizumab With Fruquintinib, Metronidazole, in Mismatch Repair-proficient or Microsatellite Stability, Advanced Colorectal Cancer: a Multicenter, Single Arm, Clinical Trial

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT05661357 2024-04-17

HCCSC-C03

Phase 4 Active not recruiting

Gastrointestinal

Colorectal Neoplasms